ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 583,38
-0,65%
Dow Jones
40 211,72
0,00%
DAX
18 508,76
-0,49%
Brent Oil
82,96
-1,64%
Bitcoin
64 124,81
-1,12%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Allos Therapeutics, Inc. (MM) (ALTH)

  7. Allos Therapeutics, Inc. (MM) (ALTH) Actualités

ALTH

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ALTH
DateHeureSourceTitreSymboleSociété
24/06/200821h52Edgar (US Regulatory)Allos Therapeutics Inc - Post-Effective Amendment to an S-8 filing (S-8 POS)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/06/200814h01Edgar (US Regulatory)Allos Therapeutics Inc - Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
13/06/200817h58Edgar (US Regulatory)Allos Therapeutics Inc - Confidential Treatment Order (CT ORDER)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
06/06/200813h00Business WireAllos Therapeutics to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/06/200821h00Business WireAllos Therapeutics Announces Interim Data from Phase 1 Study of PDX in Patients with Relapsed or Refractory Cutaneous T-Cell LymNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/05/200822h43Edgar (US Regulatory)Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/05/200822h05Edgar (US Regulatory)Allos Therapeutics Inc - Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/05/200817h15Edgar (US Regulatory)Allos Therapeutics Inc - Statement of Ownership (SC 13G)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
29/05/200821h00Business WireAllos Therapeutics Announces Closing of Public Common Stock OfferingNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/05/200813h25Edgar (US Regulatory)Allos Therapeutics Inc - Prospectus filed pursuant to Rule 424(b)(5) (424B5)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/05/200813h15Edgar (US Regulatory)Allos Therapeutics Inc - Free Writing Prospectus - Filing under Securities Act Rules 163/433 (FWP)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/05/200812h34Business WireAllos Therapeutics Announces Pricing of Public Offering of 10,800,000 Shares of Common StockNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
19/05/200812h41Business WireAllos Therapeutics Announces Public Offering of 9,000,000 Shares of Common StockNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
15/05/200812h00Business WireAllos Therapeutics Reports Interim Response and Safety Data from Pivotal Phase 2 PROPEL TrialNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/05/200822h40Edgar (US Regulatory)Allos Therapeutics Inc - Quarterly Report (10-Q)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/05/200813h30Business WireAllos Therapeutics Reports First Quarter 2008 Financial ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
06/05/200822h30Business WireAllos Therapeutics to Present at the Bank of America 2008 Healthcare ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
29/04/200820h24Edgar (US Regulatory)Allos Therapeutics Inc - Proxy Statement (definitive) (DEF 14A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
24/04/200822h00Business WireAllos Therapeutics to Report 2008 First Quarter Financial Results on May 7, 2008NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
22/04/200814h00Business WireAllos Therapeutics Completes Patient Enrollment in Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell LymphoNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
27/02/200822h54Edgar (US Regulatory)Allos Therapeutics Inc - Annual Report (10-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
27/02/200813h30Business WireAllos Therapeutics Reports 2007 ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
14/02/200821h52Edgar (US Regulatory)Allos Therapeutics Inc - Amended Statement of Ownership (SC 13G/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
11/02/200814h00Business WireAllos Therapeutics to Report 2007 Results on February 27, 2008NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
04/02/200821h23Edgar (US Regulatory)Allos Therapeutics Inc - Initial Statement of Beneficial Ownership (3)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
29/01/200814h00PR Newswire (US)Allos Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
28/01/200814h00PR Newswire (US)Allos Therapeutics Appoints Bruce K. Bennett as Vice President, ManufacturingNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/01/200814h00PR Newswire (US)Allos Therapeutics Initiates Phase 2b Study of PDX in Patients With Non-small Cell Lung CancerNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
27/12/200714h00PR Newswire (US)Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with PeriphNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
11/12/200714h00PR Newswire (US)Allos Therapeutics to Present at the 2008 JPMorgan Healthcare ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:ALTH

Dernières Valeurs Consultées

BIT
1AAG
Aumann
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés